Dr. Michelle Teng (WE ACE 2020) co-founds SynaptixBio 14 October 2021 Dr. Michelle Teng (WE ACE Cohort: 2020) co-founded SynaptixBio to develop novel lifesaving therapies for pediatric...
Dr. Anaid Benitez (WEACE 2021) selected for Phase I Cancer Tech Accelerator Programme! Anaid is developing a real-time DNA damage repair diagnostic test to assess the DNA repair capacity of tumor samples to help clinicians...
